Mindmed to present at h.c. wainwright 2nd annual psychedelics conference

New york, dec. 1, 2021 /prnewswire/ -- mind medicine (mindmed) inc. (nasdaq: mnmd), (neo: mmed), (de: mmq) (the "company"), a leading biotech company developing psychedelic-inspired therapies, today announced that mindmed's chief executive officer, robert barrow, will participate in a panel and company's management will participate in one-on-one investor meetings at the virtual h.c. wainwright 2nd annual psychedelics conference to be held on monday, december 6, 2021.
MNMD Ratings Summary
MNMD Quant Ranking